Why START? Reflections that led to the conduct of this large long-term strategic HIV trial

INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group

Article

Registro en:

The INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group. Why START? Reflections That Led to the Conduct of This Large Long-Term Strategic HIV Trial. HIV medicine, v. 16, suppl 1, p. 1–9, 2015

1464-2662

https://www.arca.fiocruz.br/handle/icict/29639

10.1111/hiv.12227

https://repositorioslatinoamericanos.uchile.cl/handle/2250/8857782

Autor

INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group

Institución

Instituto de Comunicação e Informação Científica e Tecnológica em Saúde (Brasil)

Resumen

Presentes no INSIGHT Strategic Timing of AntiRetroviral Treatment Study Group: Beatriz Grinsztejn; Sandra Wagner Cardoso (Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil).